Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006341 · ClinicalTrials.gov registry record
Validation of Predictors of OAC Initiation Using EMR Data
A clinical trial, sponsored by Boehringer Ingelheim.
- Completed
- Registry status
- 140,187
- Enrollment target
NCT03006341: Completed study, sponsored by Boehringer Ingelheim.
NCT03006341 is a clinical trial that has completed, run by Boehringer Ingelheim. The registered enrollment target is 140,187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03006341 has completed, sponsored by Boehringer Ingelheim.
- COMPLETED
- Registry status
- 140,187 participants
- Enrollment target
Study Summary
The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; second, to quantify the association between EMR-based clinical characteristics and patterns of insurance claims; third, to assess the potential for unmeasured confounding in dabigatran vs warfarin comparative effectiveness and safety studies based on administrative claims databases.
Primary Outcome
Percentage of patients with obesity; where obesity is defined as "obese, not-obese based on note of obesity or recorded body mass index (BMI) \> 30 in the electronic medical records (EMR)". The results are provided before and after propensity score (PS) matching. Before PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR whose data were available; After PS matching: all patients meeting inclusion/exclusion criteria successfully linked to EMR, 1:1 propensity
Interventions
- DRUG Warfarin
- DRUG Dabigatran etexilate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140,187 participants |
| Start Date | 2017-02-28 |
| Est. Completion | 2017-05-09 |
What the finished NCT03006341 record still lists
NCT03006341 is an observational study that tracks outcomes without assigning an intervention. Its 140,187 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Warfarin is the first listed.
NCT03006341 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03006341 about?
NCT03006341 is a clinical study titled "Validation of Predictors of OAC Initiation Using EMR Data". The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; secon...
What is the current status of trial NCT03006341?
This trial is currently completed. The enrollment target is 140,187 participants. The study started on 2017-02-28. Estimated completion is 2017-05-09.
What interventions are being tested in trial NCT03006341?
The interventions under investigation include: Warfarin (DRUG), Dabigatran etexilate (DRUG).
Who is sponsoring clinical trial NCT03006341?
This trial is sponsored by Boehringer Ingelheim, which has 515 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI